These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9224226

  • 1. Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease.
    Oren R, Beeri M, Hubert A, Kramer MR, Matzner Y.
    Arch Intern Med; 1997 Jul 14; 157(13):1474-8. PubMed ID: 9224226
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
    Murali PM, Rajasekaran S, Paramesh P, Krishnarajasekar OR, Vasudevan S, Nalini K, Lakshmisubramanian S, Deivanayagam CN.
    Respir Med; 2006 Jan 14; 100(1):39-45. PubMed ID: 15905081
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High haematocrit in haemodialysis patients can be controlled by theophylline administration.
    Vereerstraeten A, Gastaldello K, Gervy C, Vanherweghem JL, Tielemans C.
    Nephrol Dial Transplant; 1994 Jan 14; 9(2):189-91. PubMed ID: 8190338
    [Abstract] [Full Text] [Related]

  • 11. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
    Zhou Y, Wang X, Zeng X, Qiu R, Xie J, Liu S, Zheng J, Zhong N, Ran P.
    Respirology; 2006 Sep 14; 11(5):603-10. PubMed ID: 16916334
    [Abstract] [Full Text] [Related]

  • 12. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease.
    Vlahakos DV, Kosmas EN, Dimopoulou I, Ikonomou E, Jullien G, Vassilakos P, Marathias KP.
    Am J Med; 1999 Feb 14; 106(2):158-64. PubMed ID: 10230744
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Erythrocytosis after renal transplantation. The response to theophylline treatment.
    Ilan Y, Dranitzki-Elhallel M, Rubinger D, Silver J, Popovtzer MM.
    Transplantation; 1994 Mar 15; 57(5):661-4. PubMed ID: 8140628
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Erythropoietin secretion in patients with chronic obstructive lung diseases during normobaric oxygen inhalation].
    Kokot F, Franek E, Kokot M, Wiecek A, Kozielski J, Rauer R, Oklek K.
    Cas Lek Cesk; 1994 May 30; 133(11):334-7. PubMed ID: 8004661
    [Abstract] [Full Text] [Related]

  • 18. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
    Trivedi H, Lal SM.
    Ren Fail; 2003 Jan 30; 25(1):77-86. PubMed ID: 12617335
    [Abstract] [Full Text] [Related]

  • 19. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
    Montanaro D, Groupuzzo M, Boscutti G, Risaliti A, Bresadola F, Mioni G.
    Clin Nephrol; 2000 Apr 30; 53(4):suppl 47-51. PubMed ID: 10809436
    [Abstract] [Full Text] [Related]

  • 20. [Is routine monitoring of theophylline blood levels really effective?].
    Atsmon J, Priel IE, Dolev E.
    Harefuah; 1995 Nov 01; 129(9):304-8, 368. PubMed ID: 8549976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.